Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities

OBJECTIVE To estimate rates of prostate-specific antigen (PSA) testing in UK general practices by age, deprivation index and geographical location. SUBJECTS AND METHODS Practice-based, retrospective data on PSA testing patterns in 2007 were collected from a random sample of 87 general practices usin...

Full description

Bibliographic Details
Main Authors: Williams, N, Hughes, L, Turner, E, Donovan, J, Hamdy, F, Neal, D, Martin, R, Metcalfe, C
Format: Journal article
Language:English
Published: 2011
_version_ 1826292108825198592
author Williams, N
Hughes, L
Turner, E
Donovan, J
Hamdy, F
Neal, D
Martin, R
Metcalfe, C
author_facet Williams, N
Hughes, L
Turner, E
Donovan, J
Hamdy, F
Neal, D
Martin, R
Metcalfe, C
author_sort Williams, N
collection OXFORD
description OBJECTIVE To estimate rates of prostate-specific antigen (PSA) testing in UK general practices by age, deprivation index and geographical location. SUBJECTS AND METHODS Practice-based, retrospective data on PSA testing patterns in 2007 were collected from a random sample of 87 general practices using EMIS LV computer systems within the passively observed non-intervention arm of a cluster-randomized controlled trial. Information for a total of 126 716 men aged 45-89 years with no recorded diagnosis of prostate cancer prior to 1 January 2007 was collected. RESULTS In all, 7902 (6.2%) of 126 716 men aged 45-89 without a prior diagnosis of prostate cancer underwent at least one PSA test from their general practitioner during 2007 [95% confidence interval (CI) 5.6-7.0%; practice-based inter-quartile range 3.6-8.4%]. PSA testing rates were 1.4% (95% CI 1.1-1.6%) in men aged 45-49, rising to 11.3% (95% CI 10.0-12.9%) at age 75-79 years (P for trend <0.001). Testing rates were lowest in the three northern centres (3.5-5.7%) vs the three more southern centres (7.1-8.9%; P < 0.001). For every 20 points increase in the index of multiple deprivation score, the proportion of men tested fell by 1.7% (95% CI -2.5 to -0.8%; P < 0.001). Lower proportions of men were subsequently diagnosed with prostate cancer in practices testing more men (odds ratio for a one unit increase in the natural log of testing 0.76; 95% CI 0.60-0.97; P= 0.025). CONCLUSION Overall levels of PSA testing in UK general practice remain low, but for those tested there are important variations by age, deprivation and geographical location that do not appear to reflect clinical need or the intention of current policy. PSA testing in general practice is currently skewed towards older men, and current policy enabling all men to make an informed choice about PSA testing is not being effectively implemented as uptake clearly varies by socioeconomic status. This reinforces the need for robust evidence regarding the costs and benefits of using the PSA test for the detection of localized prostate cancer in the UK, a full assessment of the health economic implications and a revision of the current policy. © 2011 BJU INTERNATIONAL.
first_indexed 2024-03-07T03:09:37Z
format Journal article
id oxford-uuid:b3bc0dc6-3d5f-4b76-bb61-a5b48645cfc6
institution University of Oxford
language English
last_indexed 2024-03-07T03:09:37Z
publishDate 2011
record_format dspace
spelling oxford-uuid:b3bc0dc6-3d5f-4b76-bb61-a5b48645cfc62022-03-27T04:21:22ZProstate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English citiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b3bc0dc6-3d5f-4b76-bb61-a5b48645cfc6EnglishSymplectic Elements at Oxford2011Williams, NHughes, LTurner, EDonovan, JHamdy, FNeal, DMartin, RMetcalfe, COBJECTIVE To estimate rates of prostate-specific antigen (PSA) testing in UK general practices by age, deprivation index and geographical location. SUBJECTS AND METHODS Practice-based, retrospective data on PSA testing patterns in 2007 were collected from a random sample of 87 general practices using EMIS LV computer systems within the passively observed non-intervention arm of a cluster-randomized controlled trial. Information for a total of 126 716 men aged 45-89 years with no recorded diagnosis of prostate cancer prior to 1 January 2007 was collected. RESULTS In all, 7902 (6.2%) of 126 716 men aged 45-89 without a prior diagnosis of prostate cancer underwent at least one PSA test from their general practitioner during 2007 [95% confidence interval (CI) 5.6-7.0%; practice-based inter-quartile range 3.6-8.4%]. PSA testing rates were 1.4% (95% CI 1.1-1.6%) in men aged 45-49, rising to 11.3% (95% CI 10.0-12.9%) at age 75-79 years (P for trend <0.001). Testing rates were lowest in the three northern centres (3.5-5.7%) vs the three more southern centres (7.1-8.9%; P < 0.001). For every 20 points increase in the index of multiple deprivation score, the proportion of men tested fell by 1.7% (95% CI -2.5 to -0.8%; P < 0.001). Lower proportions of men were subsequently diagnosed with prostate cancer in practices testing more men (odds ratio for a one unit increase in the natural log of testing 0.76; 95% CI 0.60-0.97; P= 0.025). CONCLUSION Overall levels of PSA testing in UK general practice remain low, but for those tested there are important variations by age, deprivation and geographical location that do not appear to reflect clinical need or the intention of current policy. PSA testing in general practice is currently skewed towards older men, and current policy enabling all men to make an informed choice about PSA testing is not being effectively implemented as uptake clearly varies by socioeconomic status. This reinforces the need for robust evidence regarding the costs and benefits of using the PSA test for the detection of localized prostate cancer in the UK, a full assessment of the health economic implications and a revision of the current policy. © 2011 BJU INTERNATIONAL.
spellingShingle Williams, N
Hughes, L
Turner, E
Donovan, J
Hamdy, F
Neal, D
Martin, R
Metcalfe, C
Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
title Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
title_full Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
title_fullStr Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
title_full_unstemmed Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
title_short Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
title_sort prostate specific antigen testing rates remain low in uk general practice a cross sectional study in six english cities
work_keys_str_mv AT williamsn prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities
AT hughesl prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities
AT turnere prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities
AT donovanj prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities
AT hamdyf prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities
AT neald prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities
AT martinr prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities
AT metcalfec prostatespecificantigentestingratesremainlowinukgeneralpracticeacrosssectionalstudyinsixenglishcities